The multifaceted role of GLP-1 in metabolic disorders, chronic inflammation, and aging: Mechanisms and therapeutic potential
The key difference is that semaglutide users at the 2.4 mg dose report higher rates and longer duration of constipation compared to tirzepatide users, even at the highest 15 mg dose
Advisory Board
declares having received consulting honoraria from Altimmune, Amgen, Biohaven, Boehringer Ingelheim, Calibrate, Carmot Therapeutics, CinRx, Eli Lilly, Epitomee, Gila Therapeutics, IFA Celtics, Novo Nordisk, Pfizer, Rhythm, Scientific Intake, Wondr Health and Zealand Pharma
Patients should never discontinue prescribed medications without medical supervision, as abrupt cessation may result in weight regain and metabolic destabilisation